Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Vascular

This article was originally published in The Gray Sheet

Executive Summary

Inks non-exclusive agreement to provide InterVentional Technologies with a "stent cover" for pre-clinical and clinical studies designed to evaluate how the material affects stent performance. Bio-Vascular also will provide covers in commercial quantities following regulatory approval. IVT is responsible for obtaining market clearance and evaluating the cover for impact on restenosis and perforation rates, as well as effects on downstream debris during placement. IVT's LP stent, which recently received the CE mark, already incorporates the cover
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011451

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel